Scientists seek blood clues to stop cancer treatment bleeding
NCT ID NCT06824727
Summary
This study collected a single blood sample from 40 adult cancer patients with very low platelet counts. The goal was to provide fresh blood for lab testing of a potential future artificial platelet product. This research aims to help develop treatments that could reduce bleeding risks and the need for donor platelet transfusions in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.